Back to UBS Group AG UBS Group AG

IBOIBO
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in IMPACT BIOMEDICAL INC

UBS Group AG holds 2,400 shares of IBO (IMPACT BIOMEDICAL INC), worth $1,104 as of 2026-Q2. The position was decreased (-92.6% shares).

Current Value

$1,104

Current Shares

2,400

Total Value Change

+$1,098

Total Shares Change

+2,397

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2,400
-92.6%
$1,1040.0%$0.46
0
2026-Q1
Increased
32,417
+1394.6%
$19,4500.0%$0.41
20
2025-Q4
Decreased
2,169
-89.2%
$1,0950.0%$0.49
0
2025-Q3
Decreased
20,088
-49.4%
$13,3580.0%$0.66
0
2025-Q2
Increased
39,725
+145.7%
$25,7020.0%$0.75
21
2025-Q1
Increased
16,167
+280.2%
$14,0650.0%$1.52
20
2024-Q4
Increased
4,252
+1416x
$6,1650.0%$1.50
17
2024-Q3
New
3
-
$60.0%$1.97
17

Other major holders of IBO: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used